NOVO’s client Synthetic Genomics has partnered with immunotherapy development company Advaxis to establish the first current good manufacturing practice (cGMP) synthetic biology facility for the production of synthetic DNA…
NOVO’s client, Brain Corp, received the 2016 ISSA Innovation of the Year award for EMMA (Enabling Mobile Machine Automation), its AI navigation system. EMMA powers a hybrid self-driving and…
NOVO’s client, Bigfoot Biomedical, announced today a Series A investment of $35.5M to support its development of an automated insulin delivery system (sometimes referred to as an “artificial pancreas”)…
The Clinical Chemistry and Clinical Toxicity Devices Panel recommended to the FDA today that in addition to tracking and trending blood glucose concentration, patients should be able to use the Dexcom…
NOVO client SGI-DNA (a Synthetic Genomics company) was presented with the 2015 North American Synthetic Biology New Product Innovation Award for its BioXpTM 3200 “DNA printer,” which NOVO developed.…